Gene therapy injection aims to halt blindness from rare eye disorder
NCT ID NCT06699108
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This Phase 3 trial tests a gene therapy called VGR-R01 for Bietti crystalline dystrophy, a rare inherited condition that leads to progressive vision loss. The study will enroll 45 adults who receive either the gene therapy injection under the retina or a control treatment. Researchers will measure changes in visual acuity over time to see if the therapy can preserve or improve sight.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- VGR-R01 (gene therapy given as an injection under the retina)
- What this could lead to
- If it works, this could point toward a treatment that slows or stops vision loss in people with Bietti crystalline dystrophy.
- What could go wrong
- This is an early-stage Phase 3 trial with only 45 people, so results may not apply to everyone. Gene therapy carries risks like eye infection or inflammation, and it may not improve vision.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIETTI CRYSTALLINE DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Vitalgen Biopharma Co.,Ltd.
Shanghai, Shanghai Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gene therapy injection aims to restore sight in rare eye disease
- Gene therapy takes on rare eye disease in Second-Eye trial
- Can talk therapy boost the benefits of low vision aids for people with inherited eye diseases?
- AI eye doctor: new tool aims to spot rare retinal diseases
- Gene therapy trial aims to halt blindness from rare crystal disease
- New registry tracks vision loss in rare eye diseases